A genetic analysis of type 2 (non-insulin-dependent) diabetes mellitus in Punjabi Sikhs and British Caucasoid patients.

Medical Unit, London Hospital, Whitechapel, UK.
Diabetic Medicine (Impact Factor: 3.06). 11/1987; 4(6):526-30. DOI: 10.1111/j.1464-5491.1987.tb00923.x
Source: PubMed

ABSTRACT A genetic analysis of diabetic and non-diabetic Punjabi Sikhs (n = 164) was made for markers of non-insulin-dependent diabetes mellitus using insulin receptor, insulin, and HLA-D alpha chain gene probes. Additionally British Caucasoids (n = 163) were studied using the insulin receptor probe. Insulin receptor gene restriction fragment length polymorphisms were defined using Southern blot techniques and the restriction enzyme Bgl II and BAm Hl. In Punjabi Sikhs and British Caucasoids neither of the restriction fragment length polymorphisms distinguished non-insulin-dependent diabetes mellitus subjects from controls. In the Sikhs no association with non-insulin-dependent diabetes mellitus was seen with the hypervariable region of the insulin gene or with HLA-DR/DQ/DX alpha chain restriction fragment length polymorphisms. We therefore conclude that despite the high prevalence of non-insulin-dependent diabetes mellitus in Asians we were unable to find any genetic markers for this disease using the available cloned gene probes.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: HLA gene system is one of the most polymorphic regions of the human genome. The association of HLA class II genes in T1DM pathogenesis has been reported for several ethnicities. Associations of HLA class II genes with T2DM have revealed inconsistent results. Moreover, correlations between DN and HLA alleles remain unclear. We carried out DNA typing chip by specific medium resolution typing probes in 310 T2DM subjects (including 210 patients with DN and 100 patients without DN) in addition to 100 healthy controls. Differences were found between patients with T2DM and the control group in the frequencies of the HLA-DQA1∗0301 (15.5% versus 8.0%, P < 0.01) and the HLA-DQA1∗0501 alleles (16.6% versus 8.5%, P < 0.01). Differences were found between patients with DN and without DN in the frequencies of the HLA-DQA1∗0302 (6.9% versus 13.5%, P < 0.01) and HLA-DQB1∗0501 alleles (5.8% versus 14.5%, P < 0.01). Diabetes duration and systolic blood pressure were independent risk factors associated with DN (OR = 2.277 and 1.366, resp., P < 0.05), whereas the HLA-DQB1∗0501 llele had a protective effect on DN (OR = 0.53, P < 0.05). These data suggest the HLA-DQA1∗0301 and HLA-DQA1∗0501 alleles are markers of susceptibility for T2DM, and the HLA-DQB1∗0501 allele is associated with a protective effect on DN in Han ethnicity of China.
    Journal of Diabetes Research 01/2013; 2013:452537. · 3.54 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Incidence and prevalence of Type 2 Diabetes mellitus (T2DM) continue to rise in Indian populations. Despite known roles for obesity, sedentary lifestyles and diet, genetic predisposition accounts for significant risk. The identification of susceptibility loci for both monogenic and typical (oligogenic) diabetes have introduced novel genes, pathways and mechanisms of diabetes pathogenesis. Very little data is available on T2DM susceptibility loci in Asian Indian population. An extensive consortium based approach is required to identify the susceptibility locus and genes responsible for common form of familial diabetes in India. By defining the genetic susceptibility loci, such studies will eventually facilitate a direct, systematic exploration of the interactions of environmental factors, obesity, insulin resistance, and genetic predisposition in the pathogenesis of T2DM and prediabetic traits and also will open new pathways of exploration and therapy. This article is a systematic review of genetic epidemiology of adult onset Type 2 Diabetes in Asian Indian Population and related research initiatives in India and abroad.
    International Journal of Human Genetics 01/2006; 6(1):1-13. · 0.16 Impact Factor
  • Source
    Diabetes / Metabolism Reviews 01/1993; 8(4):287-338.